These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 1755459

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prediction and/or detection of ovulation by means of urinary steroid assays.
    Cekan SZ, Beksac MS, Wang E, Shi S, Masironi B, Landgren BM, Diczfalusy E.
    Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
    [Abstract] [Full Text] [Related]

  • 3. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB, Holmes J, Barker G.
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
    Blackwell LF, Vigil P, Cooke DG, d'Arcangues C, Brown JB.
    Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
    [Abstract] [Full Text] [Related]

  • 5. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay.
    Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL.
    Clin Chem; 1991 Jun; 37(6):838-44. PubMed ID: 2049848
    [Abstract] [Full Text] [Related]

  • 6. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP, Collins PO, Kilpatrick MJ, Manning PA, Pike JM, Tyler JP.
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [Abstract] [Full Text] [Related]

  • 7. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ, Miyakawa I, Goebelsmann U.
    Am J Obstet Gynecol; 1980 Jun 15; 137(4):443-50. PubMed ID: 7386528
    [Abstract] [Full Text] [Related]

  • 8. An assessment of the dual-analyte enzyme immunoassay for ovulation timing.
    Lenton EA, King H, Johnson J, Amos S.
    Hum Reprod; 1989 May 15; 4(4):378-80. PubMed ID: 2663906
    [Abstract] [Full Text] [Related]

  • 9. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
    Roos J, Johnson S, Weddell S, Godehardt E, Schiffner J, Freundl G, Gnoth C.
    Eur J Contracept Reprod Health Care; 2015 May 15; 20(6):438-50. PubMed ID: 26018113
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Day-Specific Serum LH, Estradiol, and Progesterone with MiraTM Monitor Urinary LH, Estrone-3-glucuronide, and Pregnanediol-3-glucuronide Levels in Ovulatory Cycles.
    Usala SJ, Vineyard DD, Kastis M, Trindade AA, Gill HS.
    Medicina (Kaunas); 2024 Jul 26; 60(8):. PubMed ID: 39202489
    [Abstract] [Full Text] [Related]

  • 11. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH, Campbell OM, Zacur HA, Labbok MH, MacRae SL.
    J Clin Endocrinol Metab; 1987 Apr 26; 64(4):645-50. PubMed ID: 3818896
    [Abstract] [Full Text] [Related]

  • 12. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
    Blackwell LF, Brown JB, Vigil P, Gross B, Sufi S, d'Arcangues C.
    Steroids; 2003 May 26; 68(5):465-76. PubMed ID: 12798498
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug 26; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 14. Monitoring ovarian cycle activity via progestagens in urine and feces of female mountain gorillas: A comparison of EIA and LC-MS measurements.
    Habumuremyi S, Robbins MM, Fawcett KA, Deschner T.
    Am J Primatol; 2014 Feb 26; 76(2):180-91. PubMed ID: 24123105
    [Abstract] [Full Text] [Related]

  • 15. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
    Dahl KD, Czekala NM, Lim P, Hsueh AJ.
    J Clin Endocrinol Metab; 1987 Mar 26; 64(3):486-93. PubMed ID: 3102537
    [Abstract] [Full Text] [Related]

  • 16. Using an ovarian monitor as an adjunct to natural family planning.
    Cavero C.
    J Nurse Midwifery; 1995 Mar 26; 40(3):269-76. PubMed ID: 7798132
    [Abstract] [Full Text] [Related]

  • 17. Methods of monitoring menstrual function in field studies: efficacy of methods.
    Kesner JS, Wright DM, Schrader SM, Chin NW, Krieg EF.
    Reprod Toxicol; 1992 Mar 26; 6(5):385-400. PubMed ID: 1463919
    [Abstract] [Full Text] [Related]

  • 18. Prediction of ovulation by urinary estrogen assays.
    Adlercreutz H, Lehtinen T, Kairento AL.
    J Steroid Biochem; 1980 Jan 26; 12():395-401. PubMed ID: 7421224
    [Abstract] [Full Text] [Related]

  • 19. The evolution of reference methods to monitor ovulation.
    Collins WP.
    Am J Obstet Gynecol; 1991 Dec 26; 165(6 Pt 2):1994-6. PubMed ID: 1755456
    [Abstract] [Full Text] [Related]

  • 20. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
    Merlo AB, Farinati Z, Quiroga S, Nagle CA, Carril LM, Lahoz M, Mendizabal AF.
    Int J Fertil; 1984 Dec 26; 29(3):189-93. PubMed ID: 6152260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.